“…Recently, we reported the total synthesis of solamargine using partially protected glucopyranosyl donor and an oxaza-spiro moiety in 13 steps in a 10.5% overall yield. The synthetic solamargine exhibited good cytotoxic activities against tumor cells HeLa, A549, MCF-7, K562, HCT116, U87, and HepG2 with IC50 ranging from 2.1 to 8.0 µM [8]. To further investigate the preclinical potential, we need a practical method toward large scale preparation of solamargine.…”